Morning Seminar May 31, 2006

J Infect Dis. 2006 Jun 15;193(12):1619-25.

Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses.

Erard V, Chien JW, Kim HW, Nichols WG, Flowers ME, Martin PJ, Corey L, Boeckh M.

Morning Seminar May 30, 2006

Childhood Leukemias, 2nd Ed.
Chapter 22, chronic myeloproliferative disorders: p571-582

Juvenile myelomonocytic leukemia


Blood. 2005 Jan 1;105(1):410-9.

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C, Pession A, Kabisch H, Uderzo C, Bonfim CS, Bader P, Dilloo D, Stary J, Fischer A, Revesz T, Fuhrer M, Hasle H, Trebo M, van den Heuvel-Eibrink MM, Fenu S, Strahm B, Giorgiani G, Bonora MR, Duffner U, Niemeyer CM; European Working Group on Childhood MDS; European Blood and Marrow Transplantation Group.

Morning Seminar May 25, 2006

Korean J Radiol. 2004 Apr-Jun;5(2):107-13.

Bronchiolitis obliterans after allogenic bone marrow transplantation: HRCT findings.

Jung JI, Jung WS, Hahn ST, Min CK, Kim CC, Park SH.


Ann Thorac Surg. 2005 Mar;79(3):1051-2.

Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation.

Sano Y, Date H, Nagahiro I, Aoe M, Shimizu N.

Morning Seminar May 24, 2006

Cancer. 2005 Oct 15;104(8):1661-7.

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.

Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA.

Morning Seminar May 23, 2006

Blood. 2006 Apr 25; [Epub ahead of print]

Alternating versus concurrent schedules of Imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL).

Wassmann B, Pfeifer H, Goekbuget N, Beelen DW, Beck J, Stelljes M, Bornhauser M, Reichle A, Perz J, Haas R, Ganser A, Schmid M, Kanz L, Lenz G, Kaufmann M, Binckebanck A, Bruck P, Reutzel R, Gschaidmeier H, Schwartz S, Hoelzer D, Ottmann OG.

Morning Seminar May 18, 2006

Blood. 2006 May 1;107(9):3795-803.

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD.

Carnevale-Schianca F, Cignetti A, Capaldi A, Vitaggio K, Vallario A, Ricchiardi A, Sperti E, Ferraris R, Gatti M, Grignani G, Rota-Scalabrini D, Geuna M, Fizzotti M, Sangiolo D, Sottile A, De Rosa G, Bucci AR, Lambertenghi-Deliliers G, Benedetti E, Nash R, Aglietta M.

Morning Seminar May 17, 2006

Bone Marrow Transplant. 2005 Apr;35(8):787-91.

Early measles vaccination in bone marrow transplant recipients.

Machado CM, de Souza VA, Sumita LM, da Rocha IF, Dulley FL, Pannuti CS.

Journal Club May 16, 2006

Immunity. 2006 Mar;24(3):317-27.

Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1.

Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galan JE, Askenase PW, Flavell RA.


Cancer Cell. 2006 Mar;9(3):157-73.

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K.


Cancer Cell. 2006 Mar;9(3):175-87.

The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells.

Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, Nimer SD.


Cancer Cell. 2006 Apr;9(4):287-300.

Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain.

Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, Rosenblum M, Mikkelsen T, Fine HA.


Cancer Res. 2006 Jan 1;66(1):159-67.

Distinct transcription profiles of primary and secondary glioblastoma subgroups.

Tso CL, Freije WA, Day A, Chen Z, Merriman B, Perlina A, Lee Y, Dia EQ, Yoshimoto K, Mischel PS, Liau LM, Cloughesy TF, Nelson SF.


Cancer Res. 2006 Jan 1;66(1):563-70.

Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance.

Hayashi T, Imai K, Morishita Y, Hayashi I, Kusunoki Y, Nakachi K.


Cancer Res. 2006 Jan 15;66(2):803-11.

The possible role of EWS-Fli1 in evasion of senescence in Ewing family tumors.

Matsunobu T, Tanaka K, Nakamura T, Nakatani F, Sakimura R, Hanada M, Li X, Okada T, Oda Y, Tsuneyoshi M, Iwamoto Y.


Cancer Res. 2006 Jan 15;66(2):673-81.

c-myc overexpression causes anaplasia in medulloblastoma.

Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, Eberhart CG.


Blood. 2006 Jan 1;107(1):106-10.

Runx1 function in hematopoiesis is required in cells that express Tek.

Li Z, Chen MJ, Stacy T, Speck NA.


Blood. 2006 Jan 1;107(1):197-204.

ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications.

Chiaretti S, Guarini A, De Propris MS, Tavolaro S, Intoppa S, Vitale A, Iacobelli S, Elia L, Ariola C, Ritz J, Foa R.


Blood. 2006 Jan 1;107(1):305-8.

Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis.

Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H, Yasunaga S, Takihara Y, Kimura A.


Blood. 2006 Jan 1;107(1):358-66.

Total body irradiation selectively induces murine hematopoietic stem cell senescence.

Wang Y, Schulte BA, LaRue AC, Ogawa M, Zhou D.


Blood. 2006 Jan 15;107(2):492-500.

Expression of Pitx2 in stromal cells is required for normal hematopoiesis.

Kieusseian A, Chagraoui J, Kerdudo C, Mangeot PE, Gage PJ, Navarro N, Izac B, Uzan G, Forget BG, Dubart-Kupperschmitt A.


Blood. 2006 Apr 1;107(7):2643-52.

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Serrano LM, Pfeiffer T, Olivares S, Numbenjapon T, Bennitt J, Kim D, Smith D, McNamara G, Al-Kadhimi Z, Rosenthal J, Forman SJ, Jensen MC, Cooper LJ.


Blood. 2006 Apr 1;107(7):2680-5.

Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.

Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I.


Blood. 2006 Apr 15;107(8):3131-7.

Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential.

Weerkamp F, Baert MR, Brugman MH, Dik WA, de Haas EF, Visser TP, de Groot CJ, Wagemaker G, van Dongen JJ, Staal FJ.


Blood. 2006 Apr 15;107(8):3303-12.

AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.

Nishida S, Hosen N, Shirakata T, Kanato K, Yanagihara M, Nakatsuka S, Hoshida Y, Nakazawa T, Harada Y, Tatsumi N, Tsuboi A, Kawakami M, Oka Y, Oji Y, Aozasa K, Kawase I, Sugiyama H.

Morning Seminar May 16, 2006

N Engl J Med. 2000 Apr 6;342(14):998-1006.

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Arico M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui CH, Masera G.


J Clin Oncol. 2006 Jan 20;24(3):460-6.

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.

Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, Kobayashi T, Ueda Y, Takeuchi M, Miyawaki S, Maruta A, Emi N, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group.


Blood. 2005 Jul 15;106(2):458-63.

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

Wassmann B, Pfeifer H, Stadler M, Bornhauser M, Bug G, Scheuring UJ, Bruck P, Stelljes M, Schwerdtfeger R, Basara N, Perz J, Bunjes D, Ledderose G, Mahlberg R, Binckebanck A, Gschaidmeier H, Hoelzer D, Ottmann OG.

Morning Seminar May 11, 2006

J Clin Oncol. 2006 Apr 20;24(12):1917-23.

Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.

Jeha S, Gaynon PS, Razzouk BI, Franklin J, Kadota R, Shen V, Luchtman-Jones L, Rytting M, Bomgaars LR, Rheingold S, Ritchey K, Albano E, Arceci RJ, Goldman S, Griffin T, Altman A, Gordon B, Steinherz L, Weitman S, Steinherz P.

Morning Seminar May 10, 2006

Clin Transplant. 2005 Aug;19(4):566-70.

Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation.

Hackanson B, Zeiser R, Bley TA, Pantazis G, Huzly D, Bertz H, Finke J.

Morning Seminar May 9, 2006

J Clin Oncol. 2006 Apr 1;24(10):1507-15.

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

Lapillonne H, Renneville A, Auvrignon A, Flamant C, Blaise A, Perot C, Lai JL, Ballerini P, Mazingue F, Fasola S, Dehee A, Bellman F, Adam M, Labopin M, Douay L, Leverger G, Preudhomme C, Landman-Parker J.